Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Cash Flow Quality Index
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Cash Flow Quality Index of 0.55x as of September 2025. Operating cash flow of CN¥29.28 Million is below net income of CN¥53.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Fujian Aonong Biological Technology Grou to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Fujian Aonong Biological Technology Group Incorporation Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Fujian Aonong Biological Technology Grou investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd (2014–2024)
Year-by-year earnings quality comparison for Fujian Aonong Biological Technology Group Incorporation Ltd. For live market cap and the full company financial profile, see Fujian Aonong Biological Technology Grou (603363) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.85x | CN¥-116.78 Million | CN¥63.09 Million | ▼ -553.0% |
| 2020 | 0.41x | CN¥406.02 Million | CN¥993.61 Million | ▼ -89.6% |
| 2019 | 3.93x | CN¥394.16 Million | CN¥100.36 Million | ▲ +47.6% |
| 2018 | 2.66x | CN¥27.26 Million | CN¥10.24 Million | ▲ +1113.5% |
| 2017 | 0.22x | CN¥26.78 Million | CN¥122.08 Million | ▼ -81.6% |
| 2016 | 1.19x | CN¥128.95 Million | CN¥108.35 Million | ▼ -64.4% |
| 2015 | 3.34x | CN¥129.24 Million | CN¥38.69 Million | ▲ +489.2% |
| 2014 | -0.86x | CN¥-33.66 Million | CN¥39.22 Million | — |